Public page captured October 22, 2026. Promotional sheets and temporary interface overlays were dismissed or removed in the static reference. No personal or medical information was entered. Captured entry screens do not reproduce the complete consultation.

Visual reference: News headline · creator commentary. The main campaign sends price, medication-launch, creator and celebrity ads to one Serena-led entrance. A treatment-format question sits in the hero; choosing Learn about both reveals a weight-goal question without leaving the page. Compare the creative with the destination and explore the other ads sharing this route.
Selected for its design and offer structure. Ad performance isn’t available in this collection.
The greenscreen over a real news headline borrows the feel of breaking news, which suits a launch: the viewer sees an approval story first and the brand second. The creator talks like a friend explaining something she read, covering who makes the pill, that it can be taken any time daily, and who it's for, with the line "if you're not into shots" naming a real objection in plain words. The disclosure sits right on screen ("Not a Ro member or GLP-1 patient"), which keeps the format transparent.
Because the creator is disclosed as neither a member nor a patient, there's no personal proof, so the ad is news commentary with a link at the end. The affordability claim near the close has no price attached, which leaves the most practical question unanswered after a long build-up. At 46 seconds, the payoff also arrives late. If you use this format, bring the price or offer forward and pair the commentary with a clip from a real customer.
It opens on news, which feels like information rather than an ad.
It ties the new name to a brand the viewer may already know.
It speaks to people put off by injections.
It closes on price and the next step.
No price is stated. The creator claims FDA-approved GLP-1 pills are the most affordable cash-pay options and invites viewers to see if they qualify.
The ad sends people to Ro's weight-loss quiz entry, the destination for 71 of the 100 Ro ads in the Fluid library. A quiz sits on the strongest rung of the landing-page ladder, and this one starts fast: the page opens on "Lose weight on Ro," a banner claiming "The lowest prices for GLP-1s are on Ro," a photo of Serena Williams labeled as a Ro member, and a card asking "Which Ro option are you interested in?" with GLP-1 pill, GLP-1 shot, both, or a provider recommendation as the answers. The pill answer matches the ad, but the page doesn't name Foundayo, so a viewer who clicked for the newest pill can't confirm it's the one on offer until later. Naming the new pill near the question card, or linking this ad to a pill-specific entry, would make the news-to-page handoff tighter.
Ro's main weight-loss landing page is a quiz entry: Serena Williams, labeled as a Ro member, stands beside a card asking which GLP-1 option you want. It's the destination for 71 Ro ads in the Fluid library, mostly price-led statics, Serena creator videos and pill-versus-pen product stills, nearly all ending on See if you qualify.
A pale yellow strip claims the lowest prices for GLP-1s are on Ro, the page's only answer to 'is this affordable?'
Lose weight on Ro names the category and the brand, so the visitor knows they're in the right place before reading anything else.
Serena holds a pen-style product with a Ro member label and a product thumbnail beside her, answering 'is this the thing from the ad?'
A white card asks which Ro option you're interested in (pill, shot, learn about both, or a provider recommendation), which starts the quiz and sorts visitors by how far along they are.
After Learn about both, the same card asks how much weight you're looking to lose in ranges plus Not sure yet, keeping the visitor on the page while the quiz continues.
Legal, terms, privacy and consumer health data privacy links sit beside a LegitScript Certified badge, answering 'is this a legitimate pharmacy?' for anyone who scrolls.
Read the full breakdown of this page
One of 100 Ro ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 22, 2026. We record that an ad ran publicly, not how it performed.